The Antitumor Somatostatin Analogue TT-232 Induces Cell Cycle Arrest through PKCδ and c-Src
- 13 July 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 285 (2) , 483-488
- https://doi.org/10.1006/bbrc.2001.5199
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.Proceedings of the National Academy of Sciences, 1996
- Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.Endocrinology, 1993
- Novel Somatostatin Analogs with Tyrosine Kinase Inhibitory and Antitumor ActivityBiochemical and Biophysical Research Communications, 1993
- Differential expression of somatostatin receptor subtypes in brainJournal of Neuroscience, 1992
- Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cellsEuropean Journal of Biochemistry, 1992
- G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor CellsScience, 1992
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973